Pulmonary rehabiliation: First line treatment for respiratory disease

O. Reddington, A. Telford, V. Christer, G. South (Rotherham, United Kingdom)

Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Reddington, A. Telford, V. Christer, G. South (Rotherham, United Kingdom). Pulmonary rehabiliation: First line treatment for respiratory disease. Eur Respir J 2011; 38: Suppl. 55, 4797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary rehabilitation
Source: Respipedia Article
Year: 2018

Frailty in chronic respiratory disease: direction of response to pulmonary rehabilitation
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020


Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Pulmonary rehabilitation in COPD and other chronic lung diseases
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015


Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease?
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


Pulmonary tuberculosis with acute respiratory failure: yet to be conquered
Source: Eur Respir J 2008; 32: 1667
Year: 2008


Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 821-822
Year: 2014


Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 819-821
Year: 2014


Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Pulmonary TB in asthma: A rare condition
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010


Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014

Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Immediate effects of manual therapy in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Respiratory physiotherapy assessment and techniques in COPD and asthma
Year: 2015


Diagnosis of bronchoobstruction in patients with pulmonary tuberculosis associated chronic obstructive pulmonary disease by the forced oscillation technique
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Outcomes of a pulmonary rehabilitation program in chronic obstructive pulmonary disease
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Pulmonary rehabilitation for bronchiectasis: if not now, when?
Source: Eur Respir J, 53 (1) 1802474; 10.1183/13993003.02474-2018
Year: 2019



Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016